Baxalta
North America, Illinois, United States, Illinois City
Description
Baxalta Incorporated (NYSE: BXLT) is a $6 billion global biopharmaceutical leader developing.
Investor Profile
Baxalta has made 2 investments, with 0 in the past 12 months and 50% as lead.
Stage Focus
- Series B (50%)
- Series A (50%)
Country Focus
- United States (100%)
Industry Focus
- Biotechnology
- Health Care
- Genetics
- Medical
- Biopharma
- Oncology
- Therapeutics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
